Genmab — Maj 2022
-
-
God morgen.
-
USA/lukning: Pæne stigninger efter neutralt Fed-referat https://www.proinvestor.com/investornyt/829520/usa-lukning-paene-stigninger-efter-neutralt-fed-referat
-
USA/T-bond: Uændrede renter efter nyhedsfattigt Fed-referat
https://www.proinvestor.com/investornyt/829563/usa-t-bond-uaendrede-renter-efter-nyhedsfattigt-fed-referat -
Cancer killing oncolytic virus. https://www.biospace.com/article/first-patient-dosed-with-imugene-s-cancer-killing-oncolytic-virus-drug-/
-
Her kan i signe in til newsletters from ASCO. Fierce Pharma https://firstwordpharma.com/my-account/newsletters
-
God morgen.
-
God morgen.
-
God morgen. Første sammenligning https://twitter.com/bertrandbio/status/1529938502212894724?s=21&t=nWn3U3cGuOiNogcj4OT9Zg
-
Genmab Announces Multiple Abstracts to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting https://www.proinvestor.com/investornyt/830162/genmab-announces-multiple-abstracts-to-be-presented-at-the-2022-american-society-of-clinical-oncology-asco-annual-meeting
-
Epco+R-CHOP i 1. linje dlbcl ser stærk ud. https://meetings.asco.org/abstracts-presentations/210249
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind